Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 2012 May 1;109(18):6916-21. doi: 10.1073/pnas.1114128109. Epub 2012 Apr 16.
Hypercholesterolemia, high serum cholesterol in the form of LDL, is a major risk factor for atherosclerosis. LDL is mostly degraded in the liver after its cellular internalization with the LDL receptor (LDLR). This clathrin-mediated endocytosis depends on the protein autosomal recessive hypercholesterolemia (ARH), which binds the LDLR cytoplasmic tail. Mutations in either the LDLR tail or in ARH lead to hypercholesterolemia and premature atherosclerosis. Despite the significance of this interaction for cholesterol homeostasis, no structure of either ARH or the LDLR tail is available to determine its molecular basis. We report the crystal structure at 1.37-Å resolution of the phosphotyrosine-binding (PTB) domain of ARH in complex with an LDLR tail peptide containing the FxNPxY(0) internalization signal. Surprisingly, ARH interacts with a longer portion of the tail than previously recognized, which extends to I(-7)xF(-5)xNPxY(0)QK(+2). The LDLR tail assumes a unique "Hook"-like structure with a double β-turn conformation, which is accommodated in distinctive ARH structural determinants (i.e., an extended backbone hydrogen-bonding platform, three hydrophobic helical grooves, and a hydrophobic pocket for Y(0)). This unique complementarity differs significantly in related PTB proteins and may account for the unique physiological role of these partners in the hepatic uptake of cholesterol LDL. Moreover, the unusual hydrophobic pocket for Y(0) explains the distinctive ability of ARH to internalize proteins containing either FxNPxY(0) or FxNPxF(0) sequences. Biophysical measurements reveal how mutations associated with hypercholesterolemia destabilize ARH and its complex with LDLR and illuminate LDL internalization defects seen in patients.
高胆固醇血症,即血清中 LDL 形式的高胆固醇,是动脉粥样硬化的一个主要危险因素。LDL 主要在细胞内通过 LDL 受体(LDLR)被降解。这种网格蛋白介导的内吞作用依赖于蛋白常染色体隐性高胆固醇血症(ARH),其与 LDLR 的细胞质尾巴结合。LDLR 尾巴或 ARH 中的突变导致高胆固醇血症和动脉粥样硬化的发生。尽管这种相互作用对胆固醇的动态平衡很重要,但没有 ARH 或 LDLR 尾巴的结构可以确定其分子基础。我们报告了 ARH 的磷酸酪氨酸结合(PTB)结构域与包含内吞信号 FxNPxY(0)的 LDLR 尾巴肽复合物的晶体结构,分辨率为 1.37 Å。令人惊讶的是,ARH 与尾巴的比以前认识的更长的部分相互作用,该尾巴延伸到 I(-7)xF(-5)xNPxY(0)QK(+2)。LDLR 尾巴呈现出独特的“钩状”结构,具有双β-转角构象,这在独特的 ARH 结构决定因素中得到了适应(即,扩展的骨架氢键平台、三个疏水性螺旋槽和用于 Y(0)的疏水性口袋)。这种独特的互补性在相关的 PTB 蛋白中差异显著,可能解释了这些伴侣在肝脏摄取胆固醇 LDL 中的独特生理作用。此外,Y(0)的不寻常疏水性口袋解释了 ARH 内化含有 FxNPxY(0)或 FxNPxF(0)序列的蛋白质的独特能力。生物物理测量揭示了与高胆固醇血症相关的突变如何使 ARH 及其与 LDLR 的复合物失稳,并阐明了在患者中观察到的 LDL 内吞缺陷。